Home
Search
BIO CEO & Investor Conference   |   February 10-11, 2025

Speakers & Presenters

All Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
John Temperato, BS
PRESIDENT & CEO, 9 METERS BIOPHARMA, INC.
9 Meters Biopharma, Inc.
Raleigh, North Carolina, United States
photo
Charles P. Theuer, MD, PhD
PRESIDENT & CEO, TRACON PHARMACEUTICALS, INC
TRACON Pharmaceuticals
San Diego, California, United States
photo
David Thomas
VP, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION
Resetting the innovation landscape for pain and addiction therapeutics
Washington, United States
photo
Dori Thomas-Karyat, PhD
, SYNTHIS LLC
Synthis Therapeutics
New York, New York, United States
photo
Peter Thompson
PRIVATE EQUITY PARTNER, ORBIMED ADVISORS LLC
Policy Outlook: Understanding the Effects of the U.S. Inflation Reduction Act
San Francisco, California, United States
photo
Wenzhi Tian Sr., MD
CEO, IMMUNEONCO BIOPHARMA CO., LTD
ImmuneOnco Biopharmaceuticals Inc
Shanghai, China
photo
Praveen Tipirneni
CEO, MORPHIC THERAPEUTIC, INC.
Fireside Chat: Praveen Tipirneni, MD, MBA, Chief Executive Officer, Morphic Therapeutic Inc.
Waltham, Massachusetts, United States
photo
Aracelis Torres, MPH, PhD
SENIOR VICE PRESIDENT OF CUSTOMER SOLUTIONS AND QUANTITATIVE SCIENCES, VERANA HEALTH
Integrating AI with RWE to Accelerate Path to Market
photo
Robert Towarnicki Sr., MS
PRESIDENT & CEO, SIRPANT IMMUNOTHERAPEUTICS, INC.
SIRPant Immunotherapeutics Inc.
Hummelstown, Pennsylvania, United States
photo
Joseph Tucker, PhD
CEO, ENVERIC BIOSCIENCES
Enveric Biosciences
Cambridge, Massachusetts, United States
photo
Silvan Tuerkcan, PhD
DIRECTOR, EQUITY RESEARCH, JMP SECURITIES, JMP SECURITIES
CRISPR’s Impact on Next Generation Gene Therapies
Load More